We routinely carry out comprehensive experimentation of enzyme and microbial performance at our in-house R&D labs. We aim to further substantiate nonclinical data, when aligned with customer and consumer needs, in well-designed clinical trials that meet or exceed GLP guidelines. Our clinical studies include safety and risk analyses, ad hoc statistical tests for sufficient enrollment, randomization and blinding procedures, as well as placebo controls.
Clinical Studies & Substantiation
At BIO-CAT, We Take
Clinically Validated and Substantiated
In 2019, BIO-CAT Microbials published a randomized, double-blind, placebo-controlled clinical study of probiotic supplementation in 100 healthy adults*. In 2020, we launched our first ever clinical efficacy study of enzyme supplementation and nutrient absorption. We plan to initiate more clinical studies of enzyme and Bacillus supplementation going forward.
We also invite collaboration, partnership, and co-development to help increase our bandwidth to deliver meaningful substantiation around the benefits of enzyme and probiotics supplementation.
*Penet C, Kramer R, Little R, et al. A randomized, double-blind, placebo-controlled, parallel study evaluating the efficacy of Bacillus subtilis MB40 to reduce abdominal discomfort, gas, and bloating. Altern Ther Health Med. 2019;25(12).
Your Partner From Start to Finish
Nimble operation allows extensive customization and fast lead times
With you through product selection, development, and follow-up
Guiding companies of all sizes through the regulatory process
Always innovating, giving you the confidence of solid science
Relationships with many top manufacturers to customize the process
Known for our long standing customer relationships based on trust
Learn About Our Services
Learn about enzymes, probiotics and microbials in our resource library.
Let’s Develop Something Together
We’re as passionate as you are about scientific innovation that mattersLearn More